Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
Novo Nordisk (NYSE: NVO) started the GLP-1 weight-loss revolution that is sweeping the world. Its Wegovy/Ozempic shot was…
Browsing Tag